Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Harmony Biosciences Holdings (HRMY) Long-Term Debt Issuances (2019 - 2020)

Harmony Biosciences Holdings (HRMY) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $200.0 million as the latest value for Q1 2020.

  • Quarterly Long-Term Debt Issuances changed N/A to $200.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $200.0 million through Dec 2020, changed N/A year-over-year, with the annual reading at $200.0 million for FY2023, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $200.0 million in Q1 2020 for Harmony Biosciences Holdings, up from $25.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $200.0 million in Q1 2020 to a low of $25.0 million in Q4 2019.